资讯
Metal-organic frameworks (MOFs) are a class of crystalline materials that consist of coordination bonds between transition-metal cations and multidentate organic linkers. The structure of MOFs is ...
16 天
Amazon S3 on MSNMonday OpenAI's ChatGPT New Voice Plus Images v2 & Possible Image Gen API Teased!ChatGPT Gets A New Voice Called Monday, While Sam Altman Hints At Images v2 & A Surprise Possible Image Gen API Teased Too!
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
NEW YORK - Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a developer of targeted radiotherapies, announced the introduction of ATNM-400, a new radiotherapy for prostate cancer, and detailed ...
(NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced ATNM-400, a novel, non-PSMA targeting, first in class radiotherapy for ...
Wheaton Precious Metals profits from low-cost, fixed-price metal purchase agreements. There’s a blurred line between this sector and mining. Some metals companies operate an integrated mining ...
ATNM-400 is a novel, non-PSMA targeting, first-in-class Actinium-225 radiotherapy for prostate cancer with initial preclinical results to be presented at the AACR Annual Meeting - Actinium is ...
NEW YORK - Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a developer of targeted radiotherapies, announced the introduction of ATNM-400, a new radiotherapy for prostate cancer, and ...
Plenty of companies and CEOs have made the pilgrimage to Donald Trump’s Mar-a-Lago resort to meet with the president. But small-cap biotech Actinium Pharmaceuti ...
Actinium has outlined its expanded market opportunities and expected 2025 milestones for each of its clinical programs as well as its R&D and radiopharmaceutical manufacturing capabilities as ...
Sandesh Seth, Actinium's Chairman and CEO, said, "We are honored to have this opportunity to present Actinium Pharmaceuticals and highlight the significant progress we have made in the last ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果